Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Unknown × Hyperandrogenism × Clear all

Phase

Phase NA 4 Phase 4 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Recruiting 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 25 Breast Neoplasms 18 Colorectal Neoplasms 14 Neoplasms 13 Stomach Neoplasms 12 Prostatic Neoplasms 12 Lymphoma, B-Cell 12 Burkitt Lymphoma 11 Recurrence 10 Pancreatic Neoplasms 10 Lung Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Solid Tumor 8 Lymphoma, Non-Hodgkin 8 Leukemia, Myeloid, Acute 8 Glioblastoma 8 Ovarian Neoplasms 6 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Leukemia 5 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Polycystic Ovary Syndrome 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Liver Neoplasms 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3

Interventions

Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡